216 related articles for article (PubMed ID: 25912014)
1. Organ-Specific Cancer Metabolism and Its Potential for Therapy.
Elia I; Schmieder R; Christen S; Fendt SM
Handb Exp Pharmacol; 2016; 233():321-53. PubMed ID: 25912014
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.
Martinez-Outschoorn U; Sotgia F; Lisanti MP
Semin Oncol; 2014 Apr; 41(2):195-216. PubMed ID: 24787293
[TBL] [Abstract][Full Text] [Related]
3. Warburg and Krebs and related effects in cancer.
Unterlass JE; Curtin NJ
Expert Rev Mol Med; 2019 Sep; 21():e4. PubMed ID: 31558177
[TBL] [Abstract][Full Text] [Related]
4. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
[TBL] [Abstract][Full Text] [Related]
5. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
6. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect.
Sun L; Suo C; Li ST; Zhang H; Gao P
Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):51-66. PubMed ID: 29959989
[TBL] [Abstract][Full Text] [Related]
7. Emerging concepts in bioenergetics and cancer research: metabolic flexibility, coupling, symbiosis, switch, oxidative tumors, metabolic remodeling, signaling and bioenergetic therapy.
Obre E; Rossignol R
Int J Biochem Cell Biol; 2015 Feb; 59():167-81. PubMed ID: 25542180
[TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose induces the expression of thioredoxin interacting protein (TXNIP) by increasing O-GlcNAcylation - Implications for targeting the Warburg effect in cancer cells.
Hong SY; Hagen T
Biochem Biophys Res Commun; 2015 Oct; 465(4):838-44. PubMed ID: 26315267
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and Amino Acid Alterations of the Tumor Microenvironment.
Stepka P; Vsiansky V; Raudenska M; Gumulec J; Adam V; Masarik M
Curr Med Chem; 2021; 28(7):1270-1289. PubMed ID: 32031065
[TBL] [Abstract][Full Text] [Related]
10. Targeting cancer metabolism--aiming at a tumour's sweet-spot.
Jones NP; Schulze A
Drug Discov Today; 2012 Mar; 17(5-6):232-41. PubMed ID: 22207221
[TBL] [Abstract][Full Text] [Related]
11. Drivers of the Warburg phenotype.
Cairns RA
Cancer J; 2015; 21(2):56-61. PubMed ID: 25815844
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming of the tumor.
Ferreira LM; Hebrant A; Dumont JE
Oncogene; 2012 Sep; 31(36):3999-4011. PubMed ID: 22231450
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial substrates in cancer: drivers or passengers?
Kruspig B; Zhivotovsky B; Gogvadze V
Mitochondrion; 2014 Nov; 19 Pt A():8-19. PubMed ID: 25179741
[TBL] [Abstract][Full Text] [Related]
14. 2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy.
Zhang D; Li J; Wang F; Hu J; Wang S; Sun Y
Cancer Lett; 2014 Dec; 355(2):176-83. PubMed ID: 25218591
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function.
Mouradian M; Kikawa KD; Dranka BP; Komas SM; Kalyanaraman B; Pardini RS
Mol Carcinog; 2015 Sep; 54(9):810-20. PubMed ID: 24729481
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways in breast cancer: therapeutic targeting of the microenvironment.
Nwabo Kamdje AH; Seke Etet PF; Vecchio L; Muller JM; Krampera M; Lukong KE
Cell Signal; 2014 Dec; 26(12):2843-56. PubMed ID: 25093804
[TBL] [Abstract][Full Text] [Related]
17. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
18. Towards a metabolic therapy of cancer?
Chiu M; Ottaviani L; Bianchi MG; Franchi-Gazzola R; Bussolati O
Acta Biomed; 2012 Dec; 83(3):168-76. PubMed ID: 23762991
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia-induced metabolic shifts in cancer cells: moving beyond the Warburg effect.
Weljie AM; Jirik FR
Int J Biochem Cell Biol; 2011 Jul; 43(7):981-9. PubMed ID: 20797448
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells.
Vaughan RA; Garcia-Smith R; Trujillo KA; Bisoffi M
Prostate; 2013 Oct; 73(14):1538-46. PubMed ID: 23818177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
